Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma

被引：0
|
作者：
Sangjoon Park
Yoon Jin Cha
Sang Hyun Suh
Ik Jae Lee
Kyu-Sung Lee
Chang-Ki Hong
Jun Won Kim
机构：
[1] Yonsei University College of Medicine,Department of Radiation Oncology, Gangnam Severance Hospital
[2] Yonsei University College of Medicine,Department of Pathology
[3] Yonsei University College of Medicine,Department of Radiology
[4] Yonsei University College of Medicine,Department of Neurosurgery, Gangnam Severance Hospital
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Meningioma; WHO grade I/II; Skull base neoplasm; Adjuvant radiotherapy; Surgical extent; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1351 / 1360
页数：9
相关论文
共 50 条
  • [1] Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma
    Park, Sangjoon
    Cha, Yoon Jin
    Suh, Sang Hyun
    Lee, Ik Jae
    Lee, Kyu-Sung
    Hong, Chang-Ki
    Kim, Jun Won
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (05) : 1351 - 1360
  • [2] Is Risk Group-Adapted Adjuvant Radiation Therapy Beneficial for WHO Grade I/II Skull Base Meningioma? A Propensity Score-Matched Analysis
    Park, S.
    Cha, Y. J.
    Suh, S. H.
    Lee, I. J.
    Lee, K. S.
    Hong, C. K.
    Kim, J. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E347 - E347
  • [3] Adjuvant Radiotherapy in Grade II, Atypical Meningioma of the Skull Base
    Bray, David P.
    Buster, Bryan E.
    Quillin, Joseph W.
    Press, Robert H.
    Eaton, Bree R.
    Olson, Jeffrey J.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2022, 83 (04) : 418 - 422
  • [4] Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma
    Wang, Chenyang
    Kaprealian, Tania B.
    Suh, John H.
    Kubicky, Charlotte D.
    Ciporen, Jeremy N.
    Chen, Yiyi
    Jaboin, Jerry J.
    NEURO-ONCOLOGY, 2017, 19 (09) : 1263 - 1270
  • [5] Adjuvant Radiotherapy VersusWatchfulWaiting for WHO Grade II Atypical Meningioma: A Single Institution Experience
    Bray, David
    Quillin, Joseph
    Press, Robert
    Yang, Yilin
    Wu, Jiayi
    Chen, Zhengjia
    Eaton, Bree
    Olson, Jeffrey J.
    NEUROSURGERY, 2020, 67 : 296 - 296
  • [6] Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma
    Zhou, Hao
    Bai, Harrison X.
    Chan, Lilian
    Zhang, Paul J.
    Karakousis, Giorgos
    Huang, Raymond
    Xiao, Bo
    Yang, Li
    WORLD NEUROSURGERY, 2019, 131 : E303 - E311
  • [7] SURVIVAL BENEFIT ASSOCIATED WITH ADJUVANT RADIOTHERAPY IN ELDERLY PATIENTS WITH WHO GRADE LLL MENINGIOMA
    Zhou, Hao
    Huang, Raymond
    Karakousis, Giogos
    Zhang, Paul
    Chan, Lilian
    Bai, Harrison
    Xiao, Bo
    Yang, Li
    NEURO-ONCOLOGY, 2017, 19 : 134 - 134
  • [8] Comparison of adjuvant radiation versus observation and salvage radiation after subtotal resection of a WHO grade I skull base meningioma: a propensity score-adjusted analysis
    Kosanam, Anish R.
    Ma, Jun
    White, Alexandra J.
    Murayi, Roger
    Soni, Pranay
    Recinos, Pablo F.
    Kshettry, Varun R.
    JOURNAL OF NEURO-ONCOLOGY, 2025,
  • [9] Aggressive Progression of a WHO Grade I Meningioma of the Posterior Clinoid Process: An Illustration of the Risks Associated With Observation of Skull Base Meningiomas
    Young, Isabella M.
    Yeung, Jacky
    Glenn, Chad
    Teo, Charles
    Sughrue, Michael E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [10] Clinical Efficacy of Adjuvant Radiotherapy for World Health Organization Grade II Intracranial Meningioma
    Palmieri, Mauro
    Armocida, Daniele
    De Pietro, Raffaella
    Chiarello, Giuseppina
    Rizzo, Francesca
    Garbossa, Diego
    Marampon, Francesco
    Santoro, Antonio
    Frati, Alessandro
    WORLD NEUROSURGERY, 2023, 175 : E1117 - E1123
12345